LLY delivered 48% revenue growth and raised full-year EPS guidance, yet shares sit nearly 30% below the $1,500 price target within reach. Retatrutide's BLA filing, Foundayo scaling past 36,000 ...

Eli ⁠Lilly said on Monday it would acquire privately held Merida Biosciences for up to $2.88 billion in cash, strengthening its immunology portfolio with an experimental treatment for thyroid-related ...

The Food and Drug Administration approved Eli Lilly's diabetes drug Mounjaro to cut down the risk of heart attack or stroke in high-risk adults with Type 2 diabetes. The approval gives consumers ...

NACOGDOCHES, Texas (PRESS RELEASE) - This notice has been issued due to a large leak on FM 343/CR 821, the Texas Commission on Environmental Quality has required the Lilly Grove SUD #1740014, public ...

The test, Elecsys pTau217, is a biomarker blood test that can help doctors identify patients who are likely or unlikely to have Alzheimer's-related brain changes, Roche said on Monday. Sign up here.

Eli Lilly just became the first pharmaceutical company ever valued above $1 trillion, yet analysts who dig into its pipeline are arguing the market still has not grasped what the next two years could ...

The pharmaceutical company Eli Lilly is studying a new obesity drug called retatrutide. The drug has not yet been approved by the Food and Drug Administration, but that hasn't stopped people from ...

Eli Lilly is suing six entities that it alleges are selling black market versions of its experimental weight-loss drug retatrutide. Lilly’s lawsuits target U.S. entities selling illegal retatrutide ...

Eli Lilly, the American drug giant, had another record-breaking quarter. The weight-loss injection Zepbound saw sales soar 46% in the second quarter to $4.9 billion. The FactSet consensus was for $4.7 ...

Aug 3 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would allow a limited number of patients to have early access to its experimental obesity drug, ‌retatrutide, before its U.S. FDA ...

Resilience took over AstraZeneca’s 580,000 square-foot campus in West Chester in 2022, shortly after its founding in 2020. At least 400 new jobs are coming to West Chester in 2027. Pharmaceutical ...

Eli Lilly LLY-0.65%decrease; down pointing triangle is preparing application materials for its next-generation weight-loss drug, retatrutide, following data from two Phase 3 trials showing the ...